341 related articles for article (PubMed ID: 11726572)
1. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
[TBL] [Abstract][Full Text] [Related]
2. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.
la Marca A; Egbe TO; Morgante G; Paglia T; Cianci A; De Leo V
Hum Reprod; 2000 Jan; 15(1):21-3. PubMed ID: 10611182
[TBL] [Abstract][Full Text] [Related]
4. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
Ehrmann DA; Cavaghan MK; Imperial J; Sturis J; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
[TBL] [Abstract][Full Text] [Related]
6. The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Sahin Y; Bayram F
Eur J Endocrinol; 1999 Jan; 140(1):56-61. PubMed ID: 10037253
[TBL] [Abstract][Full Text] [Related]
7. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
[TBL] [Abstract][Full Text] [Related]
8. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
9. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
10. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.
Genazzani AD; Battaglia C; Malavasi B; Strucchi C; Tortolani F; Gamba O
Fertil Steril; 2004 Jan; 81(1):114-9. PubMed ID: 14711553
[TBL] [Abstract][Full Text] [Related]
11. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ
N Engl J Med; 1996 Aug; 335(9):617-23. PubMed ID: 8687515
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
13. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
Morin-Papunen LC; Koivunen RM; Ruokonen A; Martikainen HK
Fertil Steril; 1998 Apr; 69(4):691-6. PubMed ID: 9548159
[TBL] [Abstract][Full Text] [Related]
14. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
[TBL] [Abstract][Full Text] [Related]
15. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
16. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids.
Eagleson CA; Bellows AB; Hu K; Gingrich MB; Marshall JC
J Clin Endocrinol Metab; 2003 Nov; 88(11):5158-62. PubMed ID: 14602743
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome.
la Marca A; Morgante G; Paglia T; Ciotta L; Cianci A; De Leo V
Fertil Steril; 1999 Dec; 72(6):985-9. PubMed ID: 10593368
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kouli C; Tsianateli T; Bergiele A
Eur J Endocrinol; 1998 Mar; 138(3):269-74. PubMed ID: 9539300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]